Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Supplementation in Symptomatic Benign Migratory Glossitis
NCT05190562Phase 4Completed
- Start
- Sep 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zinc in Benign migratory glossitis (BMG). Started Sep 2021; status: completed.
02
Drugs
zinc
03
Conditions
Benign migratory glossitis (BMG)
Beyond the preview
Go deeper on NCT05190562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05190562.